A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
An Open-Label Study in Healthy Male and Female Subjects to Identify the Concentration that
Provides Optimal Bioavailability of Levodopa Infused Subcutaneously via a Pump System; and to
Compare the Bioavailability of Levodopa/Carbidopa Solution to that of Levodopa/Carbidopa
Intestinal Gel (LCIG), Infused via a Naso-Jejunal Tube
Phase:
Phase 1
Details
Lead Sponsor:
NeuroDerm Ltd.
Collaborator:
Quotient Clinical
Treatments:
Carbidopa Carbidopa, levodopa drug combination Levodopa Pharmaceutical Solutions